Ian Flinn, MD

Articles by Ian Flinn, MD

Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

ByBijal D. Shah, MD,Caron Jacobson, MD,Michael Wang, MD,Ian Flinn, MD,Brian T. Hill, MD, PhD

January 29th 2022

Experts discussed the ZUMA-2 clinical trial of brexucabtagene autoleucel.

Dr. Flinn on CAR T-Cell Therapy in Non-Hodgkin Lymphoma

ByIan Flinn, MD

July 10th 2018

Ian Flinn, MD, director of the Blood Cancer Research Program, Sarah Cannon Research Institute, discusses chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin lymphoma (NHL).

Latest Updated Articles

Dr. Flinn on CAR T-Cell Therapy in Non-Hodgkin Lymphoma
July 10th 2018